Alcobra Ltd. to Participate in Upcoming Healthcare Conferences

Monday, November 7, 2016 1:01 PM UTC

TEL AVIV, Israel, Nov. 07, 2016 -- Alcobra Ltd. (Nasdaq:ADHD), an emerging pharmaceutical company focused on the development of new medications to help patients with cognitive disorders, including Attention Deficit Hyperactivity Disorder (ADHD) and Fragile X Syndrome, today announced that management will participate in several upcoming investor healthcare conferences.

*Stifel Healthcare Conference*
Date:	Tuesday, November 15
Time:	4:30PM EST
Location:	The Lotte New York Palace Hotel

*Jefferies London Healthcare Conference*
Date:	Thursday, November 17
Time:	09:20AM GMT
Location:	Waldorf Hilton, London, United Kingdom
Webcast:	http://wsw.com/webcast/jeff100/adhd

28^th Annual Piper Jaffray Healthcare Conference
Date:	Tuesday, November 29
Time:	10:00AM EST
Panel Title:	Underdiscovered Neuro-Innovators Panel
Location:	The Lotte New York Palace Hotel

*Oppenheimer Life Sciences Summit*
Date:	Tuesday, November 29
Location:	The Sofitel New York Hotel

About Alcobra

Alcobra Ltd. is an emerging pharmaceutical company primarily focused on the development and commercialization of MDX (Metadoxine Extended Release), a proprietary drug candidate to treat cognitive disorders including ADHD and Fragile X Syndrome. For more information, please visit the Company's website, www.alcobra-pharma.com, the content of which is not incorporated herein by reference.

U.S. Investor Contacts
LifeSci Advisors, LLC
Michael Rice	
646-597-6979	
[email protected]

Media Inquiries	
Sam Brown, Inc.		
Mike Beyer	
773-463-4211		
[email protected]

Israel Investor Contact:
Alcobra Investor Relations
Debbie Kaye
+972-72 2204661
[email protected]

Editor's Picks

Breathing through your nose when you exercise may make your runs easier

Entrepreneurs are facing a mental health crisis — here's how to help them

Are fish oil supplements as healthy as we think? And is eating fish better?

Will AI kill our creativity? It could – if we don’t start to value and protect the traits that make us human

Does AI have a right to free speech? Only if it supports our right to free thought

How can I lower my cholesterol? Do supplements work? How about psyllium or probiotics?

Why we need to set limits on sperm donation

Aging with a healthy brain: How lifestyle changes could help prevent up to 40% of dementia cases

Seven techniques to avoid weight regain, approved by experts

Alcobra Ltd. to Participate in Upcoming Healthcare Conferences

Editor's Picks

Welcome to EconoTimes